ArticleVirus research2026
Improved detection of rice yellow mottle virus with a polyclonal antibody xMAP assay: A high-throughput alternative to ELISA.
Article in Virus research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rice yellow mottle virus (RYMV) is one of the most destructive viral pathogens affecting rice production in sub-Saharan Africa, where its extensive genetic diversity and high evolutionary rate complicate reliable diagnosis. Current serological methods, notably double-antibody sandwich enzyme-linked immunosorbent assay (DAS-ELISA), are widely used for routine detection but may lack sensitivity when viral loads are low or samples are degraded. In this study, we developed and evaluated a high-throughput microsphere immunoassay (MIA) based on Luminex xMAP technology as an alternative serological tool for RYMV detection. A panel of three monoclonal antibodies (mABs) and one polyclonal antibody (pAB), all raised against a RYMV isolate from Madagascar, was assessed using greenhouse-propagated and field-collected rice samples representing all six known RYMV genetic groups. Assay performance was evaluated in terms of sensitivity, specificity, and accuracy using receiver operating characteristic (ROC) curve analysis, and results were compared with those obtained by DAS-ELISA. While mABs failed to retain their expected serotype specificity in the xMAP format, the polyclonal antibody enabled robust and strain-independent detection of RYMV. The pAB-based xMAP assay showed excellent diagnostic performance, with 100% specificity, sensitivity exceeding 97%, and an area under the ROC curve of 0.99. Importantly, the pAB-based xMAP assay demonstrated a 100- to 500-fold increase in sensitivity compared with DAS-ELISA, allowing reliable detection of RYMV in samples with low viral loads or compromised integrity. No cross-reactivity was observed with other co-circulating rice viruses, including maize streak virus and rice stripe necrosis virus. This study demonstrates that a polyclonal antibody-based xMAP immunoassay provides a highly sensitive, specific, and scalable alternative to conventional ELISA for RYMV diagnosis. This approach represents a promising tool for large-scale epidemiological surveys and improved management of rice viral diseases in Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.